| Drying techniques of probiotic bacteria as an important step towards the development of novel pharmabiotics G Broeckx, D Vandenheuvel, IJJ Claes, S Lebeer, F Kiekens International journal of pharmaceutics 505 (1-2), 303-318, 2016 | 289 | 2016 |
| T4-related bacteriophage LIMEstone isolates for the control of soft rot on potato caused by ‘Dickeya solani’ EM Adriaenssens, J Van Vaerenbergh, D Vandenheuvel, V Dunon, ... PloS one 7 (3), e33227, 2012 | 195 | 2012 |
| Two phages, phiIPLA-RODI and phiIPLA-C1C, lyse mono-and dual-species staphylococcal biofilms D Gutiérrez, D Vandenheuvel, B Martínez, A Rodríguez, R Lavigne, ... Applied and environmental microbiology 81 (10), 3336-3348, 2015 | 171 | 2015 |
| Bacteriophage therapy: advances in formulation strategies and human clinical trials D Vandenheuvel, R Lavigne, H Brüssow Annual review of virology 2, 599-618, 2015 | 147 | 2015 |
| Modes of action of microbial biocontrol in the phyllosphere M Legein, W Smets, D Vandenheuvel, T Eilers, B Muyshondt, E Prinsen, ... Frontiers in Microbiology 11, 544057, 2020 | 138 | 2020 |
| Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections D Vandenheuvel, A Singh, K Vandersteegen, J Klumpp, R Lavigne, ... European journal of pharmaceutics and biopharmaceutics 84 (3), 578-582, 2013 | 125 | 2013 |
| Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii M Merabishvili, D Vandenheuvel, AM Kropinski, J Mast, D De Vos, ... PloS one 9 (8), e104853, 2014 | 121 | 2014 |
| Comparing the healthy nose and nasopharynx microbiota reveals continuity as well as niche-specificity I De Boeck, S Wittouck, S Wuyts, EFM Oerlemans, MFL Van den Broek, ... Frontiers in microbiology 8, 2372, 2017 | 119 | 2017 |
| High variability in nutritional value and safety of commercially available Chlorella and Spirulina biomass indicates the need for smart production strategies M Muys, Y Sui, B Schwaiger, C Lesueur, D Vandenheuvel, P Vermeir, ... Bioresource Technology 275, 247-257, 2019 | 116 | 2019 |
| Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides CN Allonsius, MFL van den Broek, I De Boeck, S Kiekens, ... Microbial biotechnology 10 (6), 1753-1763, 2017 | 107 | 2017 |
| Characterization of Novel Bacteriophages for Biocontrol of Bacterial Blight in Leek Caused by Pseudomonas syringae pv. porri S Rombouts, A Volckaert, S Venneman, B Declercq, D Vandenheuvel, ... Frontiers in microbiology 7, 279, 2016 | 106 | 2016 |
| Inhibition of Candida albicans morphogenesis by chitinase from Lactobacillus rhamnosus GG CN Allonsius, D Vandenheuvel, EFM Oerlemans, MI Petrova, ... Scientific reports 9 (1), 2900, 2019 | 95 | 2019 |
| Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix D Vandenheuvel, J Meeus, R Lavigne, G Van den Mooter International journal of pharmaceutics 472 (1-2), 202-205, 2014 | 93 | 2014 |
| A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections K Danis-Wlodarczyk, D Vandenheuvel, HB Jang, Y Briers, T Olszak, ... Scientific reports 6 (1), 28115, 2016 | 92 | 2016 |
| Characterization of the newly isolated lytic bacteriophages KTN6 and KT28 and their efficacy against Pseudomonas aeruginosa biofilm K Danis-Wlodarczyk, T Olszak, M Arabski, S Wasik, ... PloS one 10 (5), e0127603, 2015 | 83 | 2015 |
| CIM® monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles EM Adriaenssens, SM Lehman, K Vandersteegen, D Vandenheuvel, ... Virology 434 (2), 265-270, 2012 | 83 | 2012 |
| Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage G Broeckx, D Vandenheuvel, T Henkens, S Kiekens, MFL van den Broek, ... International journal of pharmaceutics 534 (1-2), 35-41, 2017 | 82 | 2017 |
| Lactobacilli have a niche in the human nose I De Boeck, MFL van den Broek, CN Allonsius, I Spacova, S Wittouck, ... Cell reports 31 (8), 2020 | 80 | 2020 |
| Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104: H4 strain from the 2011 outbreak in Germany M Merabishvili, D De Vos, G Verbeken, AM Kropinski, D Vandenheuvel, ... PLoS One 7 (12), e52709, 2012 | 65 | 2012 |
| Hurdles in bacteriophage therapy: deconstructing the parameters J Tsonos, D Vandenheuvel, Y Briers, H De Greve, JP Hernalsteens, ... Veterinary microbiology 171 (3-4), 460-469, 2014 | 56 | 2014 |
